BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22561090)

  • 1. Pandemic (H1N1) 2009 virus infection: prolonged viral shedding and the role of corticosteroids.
    Rapose A
    J Infect; 2012 Sep; 65(3):281-2; author reply 282. PubMed ID: 22561090
    [No Abstract]   [Full Text] [Related]  

  • 2. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
    Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
    Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
    Leung YH; Lim WL; Wong MH; Chuang SK
    Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
    Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
    J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
    Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
    Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign clinical course in H1N1 2009 influenza infection in young oseltamivir-treated immunocompromised patients with kidney disease in Singapore.
    Ng KH; Quak ZX; Chan YH; Suhaila M; Lau PY; Tambyah PA; Tang JW; Yap HK
    Pediatr Infect Dis J; 2013 Mar; 32(3):298-300. PubMed ID: 23249911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
    Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
    Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
    Suhaila M; Tang JW; Lee HK; Lin C; Tambyah PA; Yap HK; Quak SH; Koay ES
    Pediatr Infect Dis J; 2011 Jul; 30(7):625-7. PubMed ID: 21206398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
    Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
    Rodríguez A; Díaz E; Martín-Loeches I; Sandiumenge A; Canadell L; Díaz JJ; Figueira JC; Marques A; Alvarez-Lerma F; Vallés J; Baladín B; García-López F; Suberviola B; Zaragoza R; Trefler S; Bonastre J; Blanquer J; Rello J;
    J Antimicrob Chemother; 2011 May; 66(5):1140-9. PubMed ID: 21385717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.
    Kumar A
    J Antimicrob Chemother; 2011 May; 66(5):959-63. PubMed ID: 21406435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection.
    Kang SJ; Park KH; Kee SJ; Shin JH; Jung SI; Kwon YS; Jang HC
    Jpn J Infect Dis; 2013; 66(5):425-7. PubMed ID: 24047743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.
    Wang YG; Jiang M; Wang RB; Zha QL; Zhang SJ; Zhou GQ; Li XW; Wang YY; Lv AP
    J Tradit Chin Med; 2012 Jun; 32(2):148-55. PubMed ID: 22876436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful salvage therapy with inhaled zanamivir in a patient with peramivir-resistant pandemic influenza A (H1N1) 2009 virus.
    Park KH; Lee SO; Choi SH; Kim MN; Lee JH; Yi H; Kim MS; Hong EH; Kim YS; Woo JH; Kim SH
    Scand J Infect Dis; 2011 Feb; 43(2):151-5. PubMed ID: 20854216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus.
    Dulek DE; Williams JV; Creech CB; Schulert AK; Frangoul HA; Domm J; Denison MR; Chappell JD
    Clin Infect Dis; 2010 Jun; 50(11):1493-6. PubMed ID: 20415572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study.
    Khoury J; Szwarcwort M; Kra-Oz Z; Saffuri M; Seh K; Yahalomi T; Braun E; Azzam ZS; Paul M; Neuberger A
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):319-323. PubMed ID: 29143145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children.
    Feiterna-Sperling C; Edelmann A; Nickel R; Magdorf K; Bergmann F; Rautenberg P; Schweiger B; Wahn V; Krüger DH; Hofmann J
    Clin Infect Dis; 2010 Dec; 51(11):e90-4. PubMed ID: 21039216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.